FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096162 [Registered on: 16/10/2025] Trial Registered Prospectively
Last Modified On: 16/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to see the result of Arjuna,Manjistha and Vasa patra churna lepa with Madhu Facial Hyperpigmentation 
Scientific Title of Study   A Pharmaco-clinical study to evaluate the effectiveness of Arjuna[Terminalia arjuna Roxb],Manjistha[Rubia cardifolia Linn] and Vasa[Adhatoda vasica Nees] patra churna lepa with Madhu in the management of Vyanga w.s.r. to melasma 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sweta Gupta 
Designation  MD Scholar 
Affiliation  State Ayurvedic College and Hospital Lucknow 
Address  P.G Dept.of dravyaguna State Ayurvedic College and Hospital Lucknow 226003 Uttar Pradesh

Lucknow
UTTAR PRADESH
226003
India 
Phone  7897489902  
Fax    
Email  gupta.sweta2020@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ramanand 
Designation  Lecturer Dravyaguna Department State Ayurvedic College and Hospital, Lucknow 
Affiliation  State Ayurvedic College and Hospital Lucknow 
Address  P.G Dept. of dravyaguna State Ayurvedic College and Hospital, Lucknow 226003 Uttar Pradesh

Lucknow
UTTAR PRADESH
226003
India 
Phone  9045699482  
Fax    
Email  dr.ramanand72@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ramanand 
Designation  Lecturer Dravyaguna Department State Ayurvedic College and Hospital, Lucknow 
Affiliation  State Ayurvedic College and Hospital Lucknow 
Address  P.G Dept. of dravyaguna State Ayurvedic College and Hospital, Lucknow 226003 Uttar Pradesh

Lucknow
UTTAR PRADESH
226003
India 
Phone  9045699482  
Fax    
Email  dr.ramanand72@gmail.com  
 
Source of Monetary or Material Support  
State Ayurvedic College and Hospital,Lucknow 
 
Primary Sponsor  
Name  State Ayurvedic College and Hospital,Lucknow 
Address  State Ayurvedic College and Hospital,Lucknow, 226003, Uttar Pradesh , India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSweta Gupta  State Ayurvedic College and Hospital,Lucknow  State Ayurvedic College and Hospital,Lucknow 226003, Uttar Pradesh , India
Lucknow
UTTAR PRADESH 
7897489902

gupta.sweta2020@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Office of Institutional ethics Committee State Ayurvedic College and Hospital Lucknow Tulsidas marg,turiyaganj pincode -226003 Uttar Pradesh 226003  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L814||Other melanin hyperpigmentation. Ayurveda Condition: VYANG,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Arjuna,Manjistha,vasa powder, Reference: Yogratnakar Kshudra Rog chikitsa Adhyaya Vyanga chikitsa Shlok no 8, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: arjuna, manjistha ,vasa churna mixed with honey will be applied locally to the affected area
2Comparator ArmDrugClassical(1) Medicine Name: Arjuna,Manjistha,Vasa powder with Honey, Reference: Yogratnakar Kshudrarog chikitsa Adhyaya Vyanga chikitsa Shlok no 8, Route: Topical, Dosage Form: Lepa Churna, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Both acute and chronic cases of vyanga with special reference to mealasma will be treated .patient willing to participate in above mentioned trial .Diagnosed with classical features of vyanga as described in samhitas. 
 
ExclusionCriteria 
Details  Age group less than 30 years and more than 50 years
Hyper pigmentation caused due to any known cases of systemic diseases like Addison disease,Cushing syndrome.
People suffering from chronic liver and renal disorders.
Hyper pigmentation caused by tumors like malignant
melanoma
Pregnant women
patients who are on chemotherapy or radiotherapy will be excluded. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Essential criteria
1 Shyavavarna[grey brown]
2 Niruja[painless]
3 Tanu[non elevated]
4 Mandal[patches with irregular border]
Non Essential criteria
1 Familial history
2 Sun exposure
Objective criteria
1 Area of lesion
2 Visibility of pigmentation 
Tthe follow up conducted during study period for once in 15 days.After completion of trial of two months ,the follow up without drug after 15th day
 
 
Secondary Outcome  
Outcome  TimePoints 
CBC
LFT,KFT
Bloodsugar[random/fasting/pp/HbA1c]
Lipid profile
Thyroid profile
 
the follow up conducted during study period for once in 15 days
After completion of trial of two months ,the follow up without drug after 15th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   04/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    Women of middle age often suffers with dark patches on face generally on cheeks forehead and nose, which often decreases their confidence and make them stressful for their appearance ,therefore i have selected this trial.This research evaluate the efficacy of arjun,manjistha and vasa powder .This research is parallel group randomised clinical study of 60 patients.
Group A [[n =30] - Arjun ,manjistha and vasa powder lepa with honey will be given for external application twice a day for a period of two months
Group B [n = 30] -  This  group is proposed to be given lepa twice along with it the powder will be also given for internal use twice daily with lukewarm water after meal  for a period of two month.
Duration of trial - 2 months
Follow up = the follow up conducted during study period for once in 15 days,after completion of trial of two months,the follow up without drug after 15 days for one month.
 
Close